The Cochrane Library: Cochrane Database of Systematic Reviews

DOI: 10.1002/14651858

Reviews/Protocols listed by Cochrane Review Group


  1. Cochrane Acute Respiratory Infections Group
  2. Cochrane Airways Group
  3. Cochrane Anaesthesia, Critical and Emergency Care Group
  4. Cochrane Back and Neck Group
  5. Cochrane Bone, Joint and Muscle Trauma Group
  6. Cochrane Breast Cancer Group
  7. Cochrane Childhood Cancer Group
  8. Cochrane Colorectal Cancer Group
  9. Cochrane Common Mental Disorders Group
  10. Cochrane Consumers and Communication Group
  11. Cochrane Cystic Fibrosis and Genetic Disorders Group
  12. Cochrane Dementia and Cognitive Improvement Group
  13. Cochrane Developmental, Psychosocial and Learning Problems Group
  14. Cochrane Drugs and Alcohol Group
  15. Cochrane Effective Practice and Organisation of Care Group
  16. Cochrane ENT Group
  17. Cochrane Epilepsy Group
  18. Cochrane Eyes and Vision Group
  19. Cochrane Fertility Regulation Group
  20. Cochrane Gynaecological, Neuro-oncology and Orphan Cancer Group
  21. Cochrane Gynaecology and Fertility Group
  22. Cochrane Haematological Malignancies Group
  23. Cochrane Heart Group
  24. Cochrane Hepato-Biliary Group
  25. Cochrane HIV/AIDS Group
  26. Cochrane Hypertension Group
  27. Cochrane IBD Group
  28. Cochrane Incontinence Group
  29. Cochrane Infectious Diseases Group
  30. Cochrane Injuries Group
  31. Cochrane Kidney and Transplant Group
  32. Cochrane Lung Cancer Group
  33. Cochrane Metabolic and Endocrine Disorders Group
    1. About this group
    2. Reviews
      1. Adenosine-diphosphate (ADP) receptor antagonists for the prevention of cardiovascular disease in type 2 diabetes mellitusReview
      2. Advice on low-fat diets for obesityReviewWithdrawn
      3. Alpha-glucosidase inhibitors for people with impaired glucose tolerance or impaired fasting blood glucoseReview
      4. Alpha-glucosidase inhibitors for type 2 diabetes mellitusReview
      5. Amifostine for salivary glands in high-dose radioactive iodine treated differentiated thyroid cancerReview
      6. Angiogenesis-inhibitors for metastatic thyroid cancerReview
      7. Angiotensin converting enzyme inhibitors in normotensive diabetic patients with microalbuminuriaReviewWithdrawn
      8. Antihypertensive therapy for preventing cardiovascular complications in people with diabetes mellitusReviewWithdrawn
      9. Antithyroid drug regimen for treating Graves' hyperthyroidismReview
      10. Aromatase inhibitors for short stature in male children and adolescentsReview
      11. Ayurvedic treatments for diabetes mellitusReview
      12. Chinese herbal medicines for benign thyroid nodules in adultsReview
      13. Chinese herbal medicines for hypercholesterolemiaReview
      14. Chinese herbal medicines for hyperthyroidismReview
      15. Chinese herbal medicines for hypertriglyceridaemiaReview
      16. Chinese herbal medicines for hypothyroidismReview
      17. Chinese herbal medicines for people with impaired glucose tolerance or impaired fasting blood glucoseReview
      18. Chinese herbal medicines for type 2 diabetes mellitusReview
      19. Chitosan for overweight or obesityReview
      20. Chromium picolinate supplementation for overweight or obese adultsReview
      21. Cinnamon for diabetes mellitusReview
      22. Colesevelam for type 2 diabetes mellitusReview
      23. Computer-assisted versus oral-and-written dietary history taking for diabetes mellitusReview
      24. Computer-assisted versus oral-and-written family history taking for identifying people with elevated risk of type 2 diabetes mellitusReview
      25. Computer-based diabetes self-management interventions for adults with type 2 diabetes mellitusReview
      26. Continuous glucose monitoring systems for type 1 diabetes mellitusReview
      27. Continuous subcutaneous insulin infusion (CSII) versus multiple insulin injections for type 1 diabetes mellitusReview
      28. Culturally appropriate health education for people in ethnic minority groups with type 2 diabetes mellitusReview
      29. Diet, physical activity, and behavioural interventions for the treatment of overweight or obesity in preschool children up to the age of 6 yearsReview
      30. Dietary advice for the prevention of type 2 diabetes mellitus in adultsReviewWithdrawn
      31. Dietary advice for treatment of type 2 diabetes mellitus in adultsReview
      32. Dipeptidyl peptidase-4 (DPP-4) inhibitors for type 2 diabetes mellitusReview
      33. Drug interventions for the treatment of obesity in children and adolescentsReview
      34. Exercise for overweight or obesityReview
      35. Exercise for type 2 diabetes mellitusReview
      36. Exercise or exercise and diet for preventing type 2 diabetes mellitusReview
      37. Glucagon-like peptide analogues for type 2 diabetes mellitusReview
      38. Green tea for weight loss and weight maintenance in overweight or obese adultsReview
      39. Group based diabetes self-management education compared to routine treatment, waiting list control or no intervention for people with type 2 diabetes mellitusReviewWithdrawn
      40. High versus low dose of initial thyroid hormone replacement for congenital hypothyroidismReview
      41. Hormone replacement therapy for women with type 1 diabetes mellitusReview
      42. 'Human' insulin versus animal insulin in people with diabetes mellitusReview
      43. Individual patient education for people with type 2 diabetes mellitusReview
      44. Inhaled insulin in diabetes mellitusReviewWithdrawn
      45. Insulin detemir versus insulin glargine for type 2 diabetes mellitusReview
      46. Insulin monotherapy compared with the addition of oral glucose-lowering agents to insulin for people with type 2 diabetes already on insulin therapy and inadequate glycaemic controlReview
      47. Insulin monotherapy versus combinations of insulin with oral hypoglycaemic agents in patients with type 2 diabetes mellitusReview
      48. Insulin secretagogues for prevention or delay of type 2 diabetes mellitus and its associated complications in persons at increased risk for the development of type 2 diabetes mellitusReview
      49. Intensive glucose control versus conventional glucose control for type 1 diabetes mellitusReview
      50. Interactive computer-based interventions for weight loss or weight maintenance in overweight or obese peopleReview
      51. Intermediate acting versus long acting insulin for type 1 diabetes mellitusReview
      52. Interventions for improving adherence to treatment recommendations in people with type 2 diabetes mellitusReview
      53. Interventions for latent autoimmune diabetes (LADA) in adultsReview
      54. Interventions for the prevention of nutritional rickets in term born childrenReview
      55. Intragastric balloon for obesityReview
      56. Iodine supplementation for preventing iodine deficiency disorders in childrenReview
      57. Iodised salt for preventing iodine deficiency disordersReview
      58. Isoflavones for hypercholesterolaemia in adultsReview
      59. Levothyroxine or minimally invasive therapies for benign thyroid nodulesReview
      60. Long-acting insulin analogues versus NPH insulin (human isophane insulin) for type 2 diabetes mellitusReview
      61. Long-term non-pharmacological weight loss interventions for adults with prediabetesReview
      62. Long-term non-pharmacological weight loss interventions for adults with type 2 diabetes mellitusReview
      63. Long-term pharmacotherapy for obesity and overweightReview
      64. Low-fat diets for acquired hypercholesterolaemiaReview
      65. Low glycaemic index, or low glycaemic load, diets for diabetes mellitusReview
      66. Low glycaemic index or low glycaemic load diets for overweight and obesityReview
      67. Meglitinide analogues for type 2 diabetes mellitusReview
      68. Metformin added to insulin therapy for type 1 diabetes mellitus in adolescentsReview
      69. Metformin monotherapy for type 2 diabetes mellitusReviewWithdrawn
      70. Momordica charantia for type 2 diabetes mellitusReview
      71. Omega-3 polyunsaturated fatty acids (PUFA) for type 2 diabetes mellitusReview
      72. Oral vitamin B12 versus intramuscular vitamin B12 for vitamin B12 deficiencyReview
      73. Parent-only interventions for childhood overweight or obesity in children aged 5 to 11 yearsReview
      74. Parenteral calcium for intensive care unit patientsReview
      75. Pentoxifylline for diabetic retinopathyReview
      76. Perioperative glycaemic control for diabetic patients undergoing surgeryReview
      77. Pharmacotherapy for weight loss in adults with type 2 diabetes mellitusReview
      78. Phosphodiesterase inhibitors for erectile dysfunction in patients with diabetes mellitusReview
      79. Pioglitazone for type 2 diabetes mellitusReview
      80. Protein and energy supplementation in elderly people at risk from malnutritionReview
      81. Protein restriction for diabetic renal diseaseReview
      82. Psychological and pharmacological interventions for depression in patients with diabetes mellitus and depressionReview
      83. Psychological interventions for overweight or obesityReviewWithdrawn
      84. Radioiodine therapy for differentiated thyroid carcinoma with thyroglobulin positive and radioactive iodine negative metastasesReview
      85. Radioiodine therapy versus antithyroid medications for Graves' diseaseReview
      86. Radioiodine treatment for pediatric Graves' diseaseReview
      87. Recombinant growth hormone for children and adolescents with Turner syndromeReview
      88. Recombinant growth hormone for idiopathic short stature in children and adolescentsReview
      89. Recombinant human thyrotropin (rhTSH) aided radioiodine treatment for residual or metastatic differentiated thyroid cancerReview
      90. Reminder systems for women with previous gestational diabetes mellitus to increase uptake of testing for type 2 diabetes or impaired glucose toleranceReview
      91. Rimonabant for overweight or obesityReview
      92. Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitusReview
      93. Rosiglitazone for type 2 diabetes mellitusReview
      94. Routine hospital admission versus out-patient or home care in children at diagnosis of type 1 diabetes mellitusReview
      95. School-based physical activity programs for promoting physical activity and fitness in children and adolescents aged 6 to 18Review
      96. Selenium supplementation for Hashimoto's thyroiditisReview
      97. Self management interventions for type 2 diabetes in adult people with severe mental illnessReview
      98. Self-monitoring of blood glucose in patients with type 2 diabetes mellitus who are not using insulinReview
      99. Short-acting insulin analogues versus regular human insulin for adults with type 1 diabetes mellitusReview
      100. Short acting insulin analogues versus regular human insulin in patients with diabetes mellitusReview
      101. Sodium-glucose cotransporter (SGLT) 2 inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at risk for the development of type 2 diabetes mellitusReview
      102. Specialist nurses in diabetes mellitusReview
      103. Subcutaneous rapid-acting insulin analogues for diabetic ketoacidosisReview
      104. Sulphonylurea monotherapy for patients with type 2 diabetes mellitusReviewWithdrawn
      105. Supportive interventions for enhancing dietary intake in malnourished or nutritionally at-risk adultsReview
      106. Surgery for the treatment of obesity in children and adolescentsReview
      107. Surgery for weight loss in adultsReview
      108. Sweet potato for type 2 diabetes mellitusReview
      109. Systems for routine surveillance in people with diabetes mellitusReviewWithdrawn
      110. Targeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitusReviewWithdrawn
      111. Thyroid hormone replacement for subclinical hypothyroidismReview
      112. Thyroid surgery for Graves’ disease and Graves’ ophthalmopathyReview
      113. Total or near-total thyroidectomy versus subtotal thyroidectomy for multinodular non-toxic goitre in adultsReview
      114. Transtheoretical model stages of change for dietary and physical exercise modification in weight loss management for overweight and obese adultsReview
      115. Vitamin C and superoxide dismutase (SOD) for diabetic retinopathyReview
      116. Vitamin D supplementation for prevention of cancer in adultsReview
      117. Vitamin D supplementation for prevention of mortality in adultsReview
      118. Weight reduction for primary prevention of stroke in adults with overweight or obesityReview
      119. Whole grain foods for the prevention of type 2 diabetes mellitusReview
      120. Zinc supplementation for the prevention of type 2 diabetes mellitus in adults with insulin resistanceReview
    3. Protocols
      1. Acupuncture for adults with type 2 diabetes mellitusProtocolWithdrawn
      2. Acupuncture for overweight or obese peopleProtocol
      3. Acupuncture for primary hypercholesterolaemiaProtocol
      4. Adjunctive bile acid sequestrant therapy for hyperthyroidism in adultsProtocol
      5. Androgen therapy for constitutional delay of growth and puberty in boysProtocol
      6. Ayurvedic herbal preparations for hypercholesterolaemiaProtocol
      7. Bromocriptine for type 2 diabetes mellitusProtocol
      8. Calcitonin testing for detection of medullary thyroid cancer in patients with thyroid nodulesProtocolDiagnostic
      9. Calcium supplementation for weight reduction in overweight or obese peopleProtocol
      10. Carbohydrate or fat-restricted diets for obesityProtocolWithdrawn
      11. Commercial weight loss products and services for obese and overweight adultsProtocolWithdrawn
      12. Continuous glucose monitoring systems for type 2 diabetes mellitusProtocolWithdrawn
      13. Dapagliflozin for type 2 diabetes mellitusProtocol
      14. Dipeptidyl-peptidase (DPP)-4 inhibitors or glucagon-like peptide (GLP)-1 analogues for prevention or delay of type 2 diabetes mellitus and its associated complications in persons at increased risk for the development of type 2 diabetes mellitusProtocol
      15. Dopamine agonists for hyperprolactinaemiaProtocol
      16. Drinking extra water or other non-caloric beverages for promoting weight loss or preventing weight gainProtocol
      17. Early nutritional therapy for malnourished or nutritionally at-risk adult medical inpatientsProtocol
      18. Exercise after bariatric surgery for obese adultsProtocol
      19. Ezetimibe for primary hypercholesterolemiaProtocolWithdrawn
      20. Fluoxetine for adult overweight or obese peopleProtocol
      21. Fructose substitution of glucose or sucrose in food for normoglycaemic persons or people with or at risk of diabetesProtocolWithdrawn
      22. Garlic for diabetes mellitusProtocolWithdrawn
      23. Herbal medicines for type 1 diabetes mellitusProtocolWithdrawn
      24. Interventions for the prevention of type 2 diabetes mellitus in women with previous gestational diabetesProtocolWithdrawn
      25. Interventions for treating overweight or obesity in adults: an overview of systematic reviewsProtocolOverview
      26. Intraoperative neuromonitoring versus visual nerve identification for prevention of recurrent laryngeal nerve injury in adults undergoing thyroid surgeryProtocol
      27. Iron supplementation for iron deficiency anemia in childrenProtocolWithdrawn
      28. Leptin for overweight and obesityProtocolWithdrawn
      29. Ligasure vessel-sealing system or harmonic scalpel versus conventional vessel ligation for thyroidectomyProtocol
      30. Lorcaserin for overweight or obese adultsProtocolWithdrawn
      31. Low- versus high-dose of radioiodine for thyroid remnant ablation in differentiated thyroid carcinoma after thyroidectomyProtocolWithdrawn
      32. Luteinising hormone releasing hormone (LHRH) analogues for children or adolescents with early puberty, idiopathic short stature or growth hormone deficiencyProtocol
      33. Metformin and sulphonylurea (second- or third-generation) combination therapy for adults with type 2 diabetes mellitusProtocol
      34. Metformin for people with impaired glucose tolerance or impaired fasting blood glucoseProtocol
      35. Minimally invasive parathyroidectomy guided by intraoperative parathyroid hormone monitoring (IOPTH) and preoperative imaging versus bilateral neck exploration for primary hyperparathyroidism in adultsProtocol
      36. Mobile phone messaging - a telemedicine for people with diabetes mellitusProtocolWithdrawn
      37. Mulberry therapy for type 2 diabetes mellitusProtocol
      38. Non-nutritive sweeteners for the prevention or treatment of being overweight or obesityProtocol
      39. Open minimally invasive versus video-assisted minimally invasive parathyroidectomy for primary hyperparathyroidismProtocol
      40. Oxandrolone for growth-hormone treated children and adolescents with Turner syndromeProtocol
      41. Patient-adjusted versus health professional-adjusted insulin dosing for type 2 diabetes mellitusProtocol
      42. Percutaneous coronary intervention versus coronary artery bypass grafting for adults with diabetes and multivessel coronary diseaseProtocolWithdrawn
      43. Pharmacological and psychosocial interventions for night eating syndrome in adultsProtocol
      44. Pioglitazone for adults with high risk of developing type 2 diabetes mellitusProtocol
      45. Pramlintide for diabetes mellitusProtocolWithdrawn
      46. Probiotic fermented milk or isolated probiotic bacteria for primary prevention of cardiovascular disease in adultsProtocolWithdrawn
      47. Psychological interventions for adults who are overweight or obeseProtocol
      48. Psychological interventions for diabetes-related distress in adults with type 2 diabetes mellitusProtocol
      49. Psychosocial interventions for the maintenance of weight loss in obese adultsProtocolWithdrawn
      50. Recombinant human thyrotropin (rhTSH) aided radioiodine treatment for non-toxic multinodular goitreProtocol
      51. Resveratrol for treatment of type 2 diabetes mellitusProtocol
      52. Scoring systems to screen for diabetic peripheral neuropathyProtocolDiagnostic
      53. Screening for type 2 diabetes mellitusProtocol
      54. Simple tests to screen for diabetic peripheral neuropathyProtocolDiagnostic
      55. Sliding scale insulin for non-critically ill hospitalised adults with diabetes mellitusProtocol
      56. Somatostatin analogues, dopamine agonists or growth hormone antagonists for pituitary adenoma-induced acromegalyProtocolWithdrawn
      57. Staple line reinforcement for adults undergoing bariatric surgery with gastric transectionProtocol
      58. Surgery versus surveillance for asymptomatic (mild) primary hyperparathyroidism in adults 50 years or olderProtocol
      59. Tai Chi for type 2 diabetes mellitusProtocol
      60. Theory-based behavioural interventions for prediabetic state and people with diabetes mellitusProtocolWithdrawn
      61. Transperitoneal versus retroperitoneal laparoscopic adrenalectomy for adrenal tumours in adultsProtocol
      62. Treatment for subclinical hyperthyroidism in adultsProtocol
      63. Ultra-long acting insulin versus long-acting insulin for type 1 diabetes mellitusProtocol
      64. Vitamin D, calcium or a combination of vitamin D and calcium for the treatment of nutritional rickets in childrenProtocolNew
      65. Vitamin D supplementation for obese adults undergoing bariatric surgeryProtocol
      66. Vitamin D supplementation for overweight or obese adultsProtocol
      67. Vitamin E supplementation for adults with diabetes mellitusProtocolWithdrawn
      68. Yoga for adults with type 2 diabetes mellitusProtocol
  34. Cochrane Methodology Review Group
  35. Cochrane Movement Disorders Group
  36. Cochrane Multiple Sclerosis and Rare Diseases of the CNS Group
  37. Cochrane Musculoskeletal Group
  38. Cochrane Neonatal Group
  39. Cochrane Neuromuscular Group
  40. Cochrane Oral Health Group
  41. Cochrane Pain, Palliative and Supportive Care Group
  42. Cochrane Pregnancy and Childbirth Group
  43. Cochrane Public Health Group
  44. Cochrane Schizophrenia Group
  45. Cochrane Skin Group
  46. Cochrane STI Group
  47. Cochrane Stroke Group
  48. Cochrane Tobacco Addiction Group
  49. Cochrane Upper GI and Pancreatic Diseases Group
  50. Cochrane Urology Group
  51. Cochrane Vascular Group
  52. Cochrane Work Group
  53. Cochrane Wounds Group

SEARCH